Modulation of bone remodeling by the gut microbiota: a new therapy for osteoporosis.

Abstract

The gut microbiota (GM) plays a crucial role in maintaining the overall health and well-being of the host. Recent studies have demonstrated that the GM may significantly influence bone metabolism and degenerative skeletal diseases, such as osteoporosis (OP). Interventions targeting GM modification, including probiotics or antibiotics, have been found to affect bone remodeling. This review provides a comprehensive summary of recent research on the role of GM in regulating bone remodeling and seeks to elucidate the regulatory mechanism from various perspectives, such as the interaction with the immune system, interplay with estrogen or parathyroid hormone (PTH), the impact of GM metabolites, and the effect of extracellular vesicles (EVs). Moreover, this review explores the potential of probiotics as a therapeutic approach for OP. The insights presented may contribute to the development of innovative GM-targeted therapies for OP.

• Authors: Zhengtian Lyu, Yongfei Hu, Yuming Guo, Dan Liu
• Journal: Bone research (Bone Res) Vol. 11 Issue 1 Pg. 31 (Jun 09 2023) ISSN: 2095-4700 [Print] China
• PMID: 37296111 (Publication Type: Journal Article, Review)
• Copyright: © 2023. The Author(s).